Aducanumab: FDA approved new drug against Alzheimer’s disease after two decades
Dr. Juni Banerjee, PhD; Neucrad Health Desk, June 26, 2021 Alzheimer’s disease (AD) affects nearly 50 million people all over...
Aducanumab
Dr. Juni Banerjee, PhD; Neucrad Health Desk, June 26, 2021 Alzheimer’s disease (AD) affects nearly 50 million people all over...
